By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

Reject
United Kingdom | EnglishEN

Current country and language: United KingdomUnited Kingdom | English (EN)

ChinaChina
GermanyGermany
IrelandIreland
ItalyItaly
SpainSpain
United KingdomUnited Kingdom

YOU ARE LEAVING THE CURRENT LANGUAGE


Breathing life into medicines

Andrew Franklin, Chief Financial Officer

Andrew joined the board of Alliance on the 28 September 2015 following his appointment as Chief Financial Officer. From 2010 to 2012, Andrew was Finance Director and Company Secretary of Genzyme Therapeutics Ltd.  Prior to that, he gained 12 years’ pharmaceutical experience with Wyeth in a variety of senior financial positions.  Andrew joins Alliance from Panasonic Europe Ltd, where he was General Manager, European Tax and Accounting. He qualified as a Chartered Accountant with Arthur Andersen in 1992 having graduated with an honours degree in Civil Engineering from the University of Wales, Cardiff in 1988.